In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...

As the Trump administration cuts thousands of federal jobs, some fired workers worry about health agencies' ability to ...

Mass firings at the FDA have decimated divisions tasked with releasing public records generated by the agency's regulatory ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

The FDA was scheduled to release its decision on Novavax’s updated, protein-based COVID-19 vaccine on April 1, but the agency ...

Peter Marks, the Food and Drug Administration (FDA) official pressured to resign over his disagreements with Health and Human ...

Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request ...

Novavax started the week hoping the FDA would issue a full approval of its Covid vaccine. But the decision never came.